Edward E. Penhoet (born December 11, 1940, in Oakland, California) co-founded Chiron, an American multinational biotechnology firm based in Emeryville, California. Chiron is known for its advancements in treatments of AIDS, hepatitis, multiple sclerosis, and kidney disease. He is the Associate Dean of the Division of Biological Sciences at the University of California, Berkeley.
He was a member of the President's Council of Advisors on Science and Technology (PCAST) from 2009 until 2017. [1] The council makes science, technology, and innovation policy recommendations to the President of the United States.
In 1963, Penhoet completed his Bachelor of Arts in biology at Stanford University, and then earned his Ph.D. in biochemistry at the University of Washington in 1968. [2] From 1968 to 1970, he was a postdoctoral fellow at the University of California in San Diego. [3]
After completing his postdoctoral fellowship in 1970, Penhoet served six years as an assistant professor at the University of California, Berkeley. He then assumed the role of associate professor in Berkeley’s Department of Biochemistry until 1983. [4] Penhoet resigned from his position as tenured faculty to concentrate on Chiron, a company he co-founded in 1981, and served as president and chief executive officer until 1998. [3] At various times during his tenure, he oversaw virtually all of Chiron’s company's activities, including research, finance, administration, human resources, manufacturing, and regulatory matters. Penhoet was on the board of directors at many biotech companies, including Zymogenetics, Chimerix, Scynexis, and Immune Design. From 1998 to 2002, Penhoet was dean of the School of Public Health at the University of California, Berkeley. [2] From 2002 until 2004, he was the chief scientific officer of the Gordon and Betty Moore Foundation, where he was also President from 2004 until 2008. [5]
Penhoet has also held roles as vice chair of the Independent Citizens oversight committee at the California Institute for Regenerative Medicine from 2004 until 2008 and director of Alta Partners from 2000 until 2016. He previously served as the chairman of Immune Design, Inc.
Penhoet has served on the board of directors of many local, state, and national organizations, including as chairman of the California Health Care Institute and the Chabot Space & Science Center boards and as a member of the San Francisco Bay Area Bioscience Center and Kaiser Permanente boards. He was elected to the Institute of Medicine of the National Academy of Sciences and was a member of the Science, Technology, and Economic Policy Board of the National Research Council, American Society of Biological Chemists, National Research Council Commission on Life Sciences, National Institutes of Health Economic Roundtable on Biomedical Research, and the American Association for the Advancement of Science. In 2009, he was an elected member of the American Academy of Arts and Sciences, the National Academy of Medicine, and the American Society for Biochemistry and Molecular Biology. [6] Also, in 2009, he was elected a member of the President's Council of Advisors on Science and Technology (PCAST), a role he held until 2017. [7]
Penhoet received the first Distinguished Faculty Award in 1991 from the Department of Molecular and Cell Biology at University of California. [8]
With Chiron co-founder, William J. Rutter, Penhoet shared the North Californian Entrepreneur of the Year Award in 1992, presented by the Ernst & Young and Inc. Magazine. [9] They also received the Harvard Business School Northern California Alumni Chapter Award for Entrepreneur of the Year in 1994. [10]
Penhoet received the 2017 Fiat Lux Faculty Award from UC Berkeley, an achievement award for faculty members whose extraordinary contributions go above and beyond the university’s philanthropic mission and transform its research, teaching, and programs.
Penhoet has also written over 50 scientific publications. The Marquis Who's Who has also listed him as a noteworthy dean, company executive, and foundation administrator. [11]
The University of California, San Francisco (UCSF) is a public land-grant research university in San Francisco, California. It is part of the University of California system and is dedicated entirely to health science and life science. It conducts research and teaching in medical and biological sciences.
The UC Berkeley College of Chemistry is one of the fifteen schools and colleges at the University of California, Berkeley. It houses the department of chemistry and the department of chemical and biomolecular engineering, both of which are ranked among the best in the world. Its faculty and alumni have won 18 Nobel Prizes, 9 Wolf Prizes, and 11 National Medals of Science.
The Walter A. Haas School of Business is the business school of the University of California, Berkeley, a public research university in Berkeley, California. It was the first business school at a public university in the United States.
The Frederick S. Pardee RAND Graduate School is a private graduate school associated with the RAND Corporation in Santa Monica, California. The school offers doctoral studies in policy analysis and practical experience working on RAND research projects to solve current public policy problems. Its campus is co-located with the RAND Corporation and most of the faculty is drawn from the 950 researchers at RAND.
The Rausser College of Natural Resources (RCNR), or Rausser College, is the oldest college at the University of California, Berkeley and in the University of California system. Established in 1868 as the College of Agriculture under the federal Morrill Land-Grant Acts, CNR is the first state-run agricultural experiment station. The college is home to four internationally top-ranked academic departments: Agriculture and Resource Economics; Environmental Science, Policy, and Management; Nutritional Sciences and Toxicology; and Plant and Microbial Biology, and one interdisciplinary program, Energy and Resources Group. Since February 2020, it is named after former dean and distinguished professor emeritus Gordon Rausser after his landmark $50 million naming gift to the college.
The President's Council of Advisors on Science and Technology (PCAST) is a council, chartered in each administration with a broad mandate to advise the president of the United States on science and technology. The current PCAST was established by Executive Order 13226 on September 30, 2001, by George W. Bush, was re-chartered by Barack Obama's April 21, 2010, Executive Order 13539, by Donald Trump's October 22, 2019, Executive Order 13895, and by Joe Biden's February 1, 2021, Executive Order 14007.
Barbara Anna Schaal American scientist, evolutionary biologist, is a professor at Washington University in St. Louis and served as vice president of the National Academy of Sciences from 2005 to 2013. She is the first woman to be elected vice president of the academy. From 2009 to 2017, Schaal served on the President's Council of Advisors on Science and Technology (PCAST).
Lubert Stryer is the Emeritus Mrs. George A. Winzer Professor of Cell Biology, at Stanford University School of Medicine. His research over more than four decades has been centered on the interplay of light and life. In 2007 he received the National Medal of Science from President Bush at a ceremony at the White House for elucidating the biochemical basis of signal amplification in vision, pioneering the development of high density microarrays for genetic analysis, and authoring the standard undergraduate biochemistry textbook, Biochemistry. It is now in its tenth edition and also edited by Jeremy Berg, Justin Hines, John L. Tymoczko and Gregory J. Gatto, Jr.
Richard H. Herman is a mathematician, currently Professor Emeritus of Mathematics, who had served as the Chancellor of the University of Illinois at Urbana-Champaign from 2005-2009. He previously served there as Provost and Vice Chancellor of Academic Affairs since 1998. As provost he garnered support for, and administered, a “faculty excellence” program designed to bring established faculty to the institution. Throughout his administrative tenure, sponsored research at the university increased by more than 50%.
The College of Biological Sciences (CBS) is one of seven freshman-admitting colleges at the University of Minnesota. Established in 1869 as the College of Science, the College of Biological Science is now located across both the Minneapolis and the St. Paul campuses. As of June 29, 2023, the dean of the College of Biological Sciences is Dr. Saara J DeWalt.
Inez Fung is a professor of atmospheric science at the University of California, Berkeley, jointly appointed in the department of earth and planetary science and the department of environmental science, policy and management. She is also the co-director of the Berkeley Institute of the Environment.
William J. Rutter is an American biochemist who cofounded the early biotechnology company Chiron Corporation together with Edward Penhoet and Pablo DT Valenzuela. As chairman of the department of biochemistry and biophysics of the University of California, San Francisco, Rutter helped establish that department as a leader in the academic side of the biotechnology during the San Francisco Bay Area biotech boom of the 1980s.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.
Rosina M. Bierbaum is currently the Roy F. Westin Chair in Natural Economics and Research Professor at the University of Maryland's School of Public Policy. She is also a professor and former dean at the University of Michigan School of Natural Resources and Environment (SNRE). She was hired in October 2001, by then-University of Michigan President, Lee Bollinger. She is also the current Chair of The Scientific and Technical Advisory Panel (STAP) that provides independent scientific and technical advice to the GEF on its policies, strategies, programs, and projects.
Pablo Valenzuela is a Chilean biochemist dedicated to biotechnology development. He is known for his genetic studies of hepatitis viruses; participated as R&D Director in the discovery of hepatitis C virus and the invention of the world's first recombinant vaccine. He is one of the cofounders of the biotechnology company Chiron Corporation and of Fundacion Ciencia para la Vida, a private non profit institution where he is currently working.
Andrea Goldsmith is an American electrical engineer and the Dean of Engineering and Applied Science at Princeton University. She is also the Arthur LeGrand Doty Professor of Electrical Engineering at Princeton. She was previously the Stephen Harris Professor in the School of Engineering at Stanford University, as well as a faculty affiliate at the Stanford Neurosciences Institute. Her interests are in the design, analysis and fundamental performance limits of wireless systems and networks, and in the application of communication theory and signal processing to neuroscience. She also co-founded and served as chief technology officer of Plume WiFi and Quantenna Communications. Since 2021, she has been a member of the President’s Council of Advisors on Science and Technology (PCAST).
Chandan K. Sen is an Indian-American scientist who is known for contributions to the fields of regenerative medicine and wound care. He is currently the Director of the McGowan Institute for Regenerative Medicine of the University of Pittsburgh. He is a University Endowed Professor of Surgery who also serves as the Chief Scientific Officer of wound care services of the University of Pittsburgh Medical Center health system. At the University of Pittsburgh, Professor Sen serves as Associate Vice Chancellor for Life Sciences Innovation and Commercialization.
A. Eugene Washington is an American physician, clinical investigator, and administrator. He served as the chancellor for health affairs at Duke University, and the president and chief executive officer of the Duke University Health System, from 2015 to 2023. His research considers gynaecology, health disparities, and public health policy. He was elected to the National Academy of Medicine in 1997 and the American Academy of Arts and Sciences in 2014.